^
Association details:
Biomarker:No biomarker
Cancer:Bowens Disease
Drug:5-fluorouracil (Thymidylate synthase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
07/14/2020
Excerpt:
The NCCN panel discussed the use of alternative therapies for first-line treatment in patients with SCC in situ (Bowen’s disease)...alternative therapies the panel recommends considering include 5-FU…